Literature DB >> 14212857

PLASMA KININS AND OTHER VASOACTIVE COMPOUNDS IN ACUTE INFLAMMATION.

G P LEWIS.   

Abstract

Keywords:  BLOOD; ENZYME PRECURSORS; HISTAMINE LIBERATION; INFLAMMATION; KALLIKREIN; KININS; LYMPH; PEPTIDES; PHARMACOLOGY; SEROTONIN; VASOMOTOR SYSTEM

Mesh：

Substances：

Year:  1964        PMID： 14212857     DOI： 10.1111/j.1749-6632.1964.tb52550.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  10 in total

1.  ON SOME ANTAGONISTS OF BRADYKININ.

Authors:  M ROCHAESILVA; J GARCIALEME
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1965-02-16

2.  Methionyl-lysyl-bradykinin, a new kinin from ox blood.

Authors:  D F Elliott; G P Lewis
Journal:  Biochem J       Date:  1965-05       Impact factor: 3.857

Review 3.  Participation of components of the blood coagulation system in the inflammatory response.

Authors:  D G McKay
Journal:  Am J Pathol       Date:  1972-04       Impact factor: 4.307

4.  Immune reactions and kinin formation in chronic trypanosomiasis.

Authors:  P F Boreham
Journal:  Br J Pharmacol Chemother       Date:  1968-03

5.  Effect of anti-proteases and hexadimethrine bromide on the release of a bradykinin-like substance during heating (46 degrees C) of rat paws.

Authors:  J Garcia Leme; L Hamamura; M Rocha e Silva
Journal:  Br J Pharmacol       Date:  1970-10       Impact factor: 8.739

6.  Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases. Origin and relation to disease category.

Authors:  M K Jasani; M Katori; G P Lewis
Journal:  Ann Rheum Dis       Date:  1969-09       Impact factor: 19.103

7.  Studies on the relative effects of prostaglandins, bradykinin, 5-hydroxytryptamine and histamine on the synovial microcirculation in dogs.

Authors:  W C Dick; D M Grennan; I J Zeitlin
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

8.  Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.

Authors:  M R Klemperer; V H Donaldson; F S Rosen
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

9.  Inflammatory changes in tumour vessels after systemic 5-hydroxytryptamine, bradykinin, kallikrein, or lysolecithin.

Authors:  D B Cater; C R Taylor
Journal:  Br J Cancer       Date:  1966-09       Impact factor: 7.640

10.  Effects of vasomotor drugs and "mediators" of the inflammatory reaction upon the oxygen tension of tumours and tumour blood-flow.

Authors:  D B Cater; H M Adair; C A Grove
Journal:  Br J Cancer       Date:  1966-09       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.